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Introduction: The aim of the present study was to investigate the effects of mindfulness-based cognitive therapy (MBCT) on suicidal
ideation in an open-label randomised controlled trial of patients with residual depressive symptoms. Furthermore, this study aimed at
examining whether an effect of MBCT on suicidal ideation was dependent on a reduction in depression severity, worry and rumination, or an
increase in mindfulness.
Methods: One hundred and thirty participants were randomised to a treatment arm (treatment as usual plus MBCT) or a wait list arm. Change
in depression, change in worry, change in rumination and change in mindfulness were entered as covariates in a repeated measures ANOVA
in order to assess to what degree MBCT-induced changes in suicidal ideation were independent from changes in these parameters.
Results: There was a significant group × time (pre vs. post) interaction on suicidal ideation indicating a significant reduction of suicidal
ideation in the MBCT group, but not in the control group. The interaction remained significant after addition of the above covariates. Change
in worry was the only covariate associated with change in suicidal ideation, causing a moderate reduction in the interaction effect size.
Conclusions: The results suggest that MBCT may affect suicidal ideation in patients with residual depressive symptoms and that this effect
may be mediated, in part, by participants’ enhanced capacity to distance themselves from worrying thoughts.
© 2014 Elsevier Inc. All rights reserved.1. Introduction
Suicidal ideation has been shown to be a major risk factor
for suicidal behaviour and is associated with depression.
Several population-based studies revealed point prevalences
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0010-440X/© 2014 Elsevier Inc. All rights reserved.5% up to 10% [1–4]. In clinical samples, the prevalence of
suicidal ideation is much higher. In a meta-analysis, the risk
for completed suicide in patients who had ever been
hospitalised for suicidality was 8.6% and, for hospitalised
patients with affective disorders without specification of
suicidality, the lifetime risk was 4.0% [5]. Nock et al. noted
that half of those who considered ending their lives (suicidal
ideation) had a prior mental disorder [6]. Major depressive
disorder in particular is an important predictor for suicidal
ideation and behaviour [1,7,8].
However, despite being correlated with depression, recent
evidence suggests that suicidal ideation may be more than a
symptom or mere consequence of an affective disorder.
Leboyer and colleagues [9] noted that suicidal thoughts and
behaviour might constitute a potentially isolated psycholog-
ical phenomenon, partially independent from other expres-
sions of psychopathology [10,11]. Diefenbach and
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stated that suicidal ideation may be associated with non-
specific subclinical psychopathological features such as
emotional instability, together with anxiety, social inhibition,
and possibly hostility and negative affectivity. A number of
recent studies on developing or evaluating self-report
instruments for the assessment of depression reported that
it may be challenging to incorporate suicidality in a
unidimensional scale for depression [13–15]. For example,
Forkmann and colleagues [15] and Kendel and coworkers
[15] found that the suicidal ideation item of the depression
module of the Patient Health Questionnaire [16] did not fit a
unidimensional Rasch model. Accordingly, Van Orden and
colleagues [17] proposed that suicide risk assessment should
be included in DSM-5 [18] on a separate sixth axis. Indeed,
in DSM-5, the category “suicidal behavior disorder” is part
of Section 3.
If suicidal ideation is not merely a component of
depression but instead represents a potentially isolated
psychological phenomenon, or even a separate nosological
entity, the implication is that treatments aimed at reducing
depression may not necessarily impact also on suicidal
ideation. A recent meta-analysis highlights the fact that there
is insufficient evidence for the assumption that suicidal
ideation in depressed patients can be reduced with
psychotherapy for depression—although this is the recom-
mended type of intervention for depression [19]. The authors
stress that the results of their analyses suffer from limited
statistical power due to the small number of available trials
and suggest that there is a need for additional randomised
controlled trials that measure suicidal ideation, suicide risk,
and attempted or completed suicides as outcomes.
1.1. Mindfulness-based cognitive therapy
A prominent variant of the so-called third-wave ap-
proaches to psychotherapy is mindfulness-based cognitive
therapy (MBCT). Mindfulness-based cognitive therapy is a
group-based 8-week meditation exercise combined with
cognitive behavioural techniques [20]; it aims at focusing on
the “here and now” in order to engage with momentary
experience and to redirect attention whenever it has switched
to distracting thoughts and worries. Moreover, MBCT
promotes the cultivation of an open, mild and curious
orientation of mind. This refers to experiencing the present
moment without judgement or evaluation and without
worrying about the future or ruminating about the past
[21]. Mindfulness-based cognitive therapy has been proven
to significantly reduce relapse risk after remission of a
depressive episode [22,23], and also appears effective for
acute phase treatment of various severity levels of current
depression [24–27]. Geschwind and colleagues [28] found
that MBCT was associated with increased levels of
momentary positive emotions and greater appreciation of
pleasant daily-life activities. Van Aalderen and colleagues
[29] showed that the efficacy of MBCT, as compared withtreatment as usual (TAU) in reducing levels of depression,
was mediated by decreases in worry and rumination and
increases in the mindfulness skill “accepting without
judgement”. Recently, Batink and coworkers [30] showed
that changes in momentary positive and negative affect
significantly mediated the efficacy of MBCT and the effect
of changes in worry on depressive symptoms.
Although MBCT originally was developed to prevent
depressive relapse, it may be also suitable for patients with
suicidal ideation and behaviour [31]. Williams and col-
leagues [32] propose that MBCT may help prevent
recurrence of suicidal crises by targeting cognitive reactivity
to sad mood in periods of remission. Cognitive reactivity is
assumed to be a process by which small deteriorations in
mood may reactivate cognitive patterns that were active in
past episodes but hidden in remission [33]. Mindfulness-
based cognitive therapy may target cognitive reactivity by
enabling people to adopt a different, more decentred
relationship with their own thoughts, feelings and body
sensations, thus preventing these experiences from launching
a downward mood spiral that would otherwise have led to
another suicidal crisis [32,34].
However, there is equivocal evidence for the efficacy of
MBCT for suicidal ideation and clear conclusions are
impeded by a lack of randomised controlled trials.
Dialectical behaviour therapy (including mindfulness train-
ing) was shown to successfully reduce suicidal behaviour in
borderline personality disorder [35]. Barnhofer and colleages
[36] examined the effects of MBCT plus TAU in comparison
to TAU alone in a sample of 28 patients suffering from
chronic depression with a history of suicidal ideation and
behaviour. Results suggested a significant effect of MBCT
on depression but not on suicidal ideation [36]. The effect
size sensu Cohen [37] for the difference between pre-
and post-treatment assessments in the MBCT group was
d = 0.48. Thus, this effect possibly would have approached
significance in a larger sample with sufficient power.
The results of these studies suggest that MBCT may
confer positive effects on suicidal ideation and behaviour;
however, evidence is equivocal and limited. To the best of
our knowledge, no data have been published examining the
effect of MBCT on suicidal ideation in a large randomised
controlled trial with a sample of patients with residual
depressive symptoms after acute depression.
1.2. Aims of the current study
The current study is a secondary analysis of the Mind-
Masstricht study [trial number NTR1084; 28]. The primary
aim of the present investigation was to examine the effects of
MBCT on suicidal ideation in an open-label randomised
controlled trial comparing participants with residual depres-
sive symptoms after at least one episode of major depressive
disorder who were randomly assigned to a wait list
condition, with participants who received MBCT. A second
aim was to examine whether an effect of MBCT on suicidal
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worry, and rumination, or an increase in mindfulness. To
pursue these goals, secondary analyses were performed
using data acquired in a comprehensive research project
conducted at Maastricht University Medical Centre. Details
of the central research questions and primary results can be
found elsewhere [25,28].2. Methods
2.1. Sample
In the MindMaastricht study (trial number NTR1084,
Netherlands Trial Register Trial registration: http://www.
trialregister.nl/trialreg/admin/rctview.asp?TC=1084) [28],
adults with residual depressive symptomatology (≥7 on
the 17-item Hamilton Depression Rating Scale (HDRS)
[38]), after at least one episode of major depressive disorder
(MDD) were recruited from outpatient mental health care
facilities in Maastricht and through posters in public spaces.
As the focus was on stable residual symptomatology in the
context of a previous affective disorder, individuals were
excluded if they met SCID criteria for a current depressive
episode, schizophrenia, or any psychotic disorder in the past
year, and recent (past four weeks) or upcoming changes in
ongoing psychological or pharmacological treatment. Sam-
ple sociodemographic and clinical characteristics are dis-
played in Table 1. There were no significant differences
between groups (p b 0.05) at baseline.
2.2. Sampling procedures
All study procedures were approved by the Medical
Ethics Committee of Maastricht University Medical Centre,
and all participants signed an informed consent form. Initial
screening was performed by phone to check for availability
during the study period and the likelihood of meeting in- and
exclusion criteria. A second screening included the admin-
istration by trained psychologists of the Structured Clinical
Interview for DSM IV axis I [39] and the 17-item HDRS.Table 1
Baseline demographic and clinical characteristics per group.
MBCT
(n = 64)
CONTROL
(n = 66)
Age (mean, SD) 44.6 (9.7) 43.2 (9.5)
Female gender 79% 73%
Full-/part-time work 62% 68%
Illness/unemployment benefits 19% 23%
Living with partner/own family 64% 64%
Comorbid anxiety disorder (present) 35% 49%
Comorbid anxiety disorder (past) 51% 64%
Current psycho-counseling/-therapy 13% 12%
Current use of antidepressants 32% 38%
(Occasional) use of benzodiazepines 8% 8%
There were no significant differences between groups (at p b 0.05).
MBCT = Mindfulness-based cognitive therapy; CONTROL = waitlist con-
trol condition.Eligible participants took part in the baseline assessment,
after which they were randomised to either the MBCT or
waiting list (allocation ratio 1:1). After either eight weeks of
MBCT (see below) or the equivalent waiting time (control
group), participants took part in the post-intervention
assessment. All participants were compensated with gift
vouchers worth 50 euros. Participants in the control group
had the opportunity to take part in MBCT after the post-
intervention assessment.2.3. Randomisation
Randomisation to the treatment condition was stratified
according to the number of depressive episodes (two or less
versus three or more) as, at the time of randomisation, studies
suggested a greater benefit for those with three or more
previous episodes [40]. An independent researcher not
involved in the project generated the randomisation sequence
in blocks of five (using the sequence generator on www.
random.org), and wrote the randomisation code into sealed
numbered envelopes. After completion of all baseline
assessments, the researcher allocated participants to their
treatment group based on the randomisation code in the
sealed envelope (opened in order of sequence). No masking
of treatment condition took place.2.4. Mindfulness-based cognitive therapy
The content of MBCT training sessions followed the
protocol of Segal, Williams and Teasdale [20]. Training
consisted of eight weekly meetings lasting 2.5 h and were
run in groups of 10–15 participants. Sessions included
guided meditation, experiential exercises and discussion. In
addition to the weekly group sessions, participants received
CDs with guided exercises and were assigned daily
homework exercises (30 to 60 min daily). Training sessions
were given by experienced trainers in a centre specialising in
mindfulness training. All trainers were supervised by an
experienced health care professional who had trained with
Teasdale and Williams, the co-developers of MBCT [41].2.5. Measures
2.5.1. Kentucky Inventory of Mindfulness Skills
The Dutch version of the Kentucky Inventory of
Mindfulness Skills (KIMS) [42] measures the presence of
mindful skills in daily life. It is a 36-item self-report
instrument designed to measure mindfulness skills. Items are
rated on a 5-point Likert-scale ranging from “never or very
rarely true” (1) to “always or almost always true” (5). Higher
scores indicate the presence of more mindful skills. A total
KIMS score can be calculated indicating the extent of overall
mindfulness skills. Prior research has reported reasonable
correlations of the KIMS with a variety of other clinical
constructs [42,43].
1886 T. Forkmann et al. / Comprehensive Psychiatry 55 (2014) 1883–18902.5.2. Hamilton Depression Rating Scale
The 17-item HDRS [38] was administered by two trained
research assistants with master’s degrees in psychology. The
HDRS is a semistructured interview designed to assess
depressive symptoms over the past week. It is one of the most
often used rating scales in depression research, and internal,
interrater, and retest reliability estimates for the overall
HDRS are good [44]. Only the overall score was used for the
analyses, and interrater reliability for the total score was high
(intraclass correlation coefficient α = 0.97). In order to
assess interrater reliability, both interviewers had indepen-
dently rated eight videotaped HDRS interviews with patients
varying in the strength of their residual depressive symptoms.
2.5.3. Penn State Worry Questionnaire (PSWQ)
The PSWQ is a 16-item (5-point Likert scale) self-report
instrument that measures the concept of worry [45,46].
Internal consistency (Cronbach’s alpha) in the present
sample was α = 0.90.
2.5.4. Rumination on Sadness Scale (RSS)
The Dutch version [47] of the RSS [48] was used to
measure rumination. The instrument consists of 13 items that
load on one factor. It has good convergent and discriminant
validity and internal consistency [48]. In the present sample,
internal consistency was α = 0.90.
2.5.5. Suicidal ideation
Suicidal ideation was measured using the respective item
from the self-rating form of the Dutch version of the
Inventory of Depressive Symptoms [49]. This item asks for
thoughts about death and suicide in the past seven days.
Answers can be given on a 4-point scale ranging from 0 (I do
not think of suicide or death) to 3 (I think of suicide or death
several times a day in depth, or have made specific plans, or
attempted suicide). This item has been used successfully as
an indicator for suicidal ideation in some clinical studies
[50–52].
2.6. Statistical analysis
First, we examined the effects of MBCT on change in
suicidal ideation relative to the control condition by
conducting an analysis of variance for repeated measures
(ANOVA). Thus, in the models of suicidal ideation, the two-
way interaction between study period (baseline vs. post
assessment) and treatment group (control vs. MBCT) was the
parameter of interest. Change in depression (HDRS without
suicide item), change in mindfulness (KIMS total), change in
worry (PSWQ), and change in rumination (RSS) subse-
quently were entered as covariates to examine whether
changes in suicidal ideation were independent from changes
in these parameters. Change scores were calculated as
difference scores between baseline and post assessment. The
suicide item was excluded from the HDRS sum scores to
avoid overlapping and thus part-whole correlations. We
controlled for homogeneity of error variances. This is
important in order to interpret validly the results ofMANOVA. In the case of significant results of the Mauchly
test, and thus violation of homogeneity of error variances, a
Greenhouse–Geisser correction was implemented. When
significant interactions occurred, post-hoc pairwise compar-
isons were calculated to identify the source of the significant
interaction effects.3. Results
3.1. Participants
Recruitment of participants started in January 2008 and
ended in February 2009; all post-intervention assessments
were completed by August 2009, when the pre-determined
number of participants was reached. At baseline, there were
no significant differences between groups with respect to
socio-demographic and clinical characteristics (Table 1).
Table 2 shows the baseline assessment scores of variables
used in the analyses, stratified by treatment group. Again,
there were no significant differences between groups at
baseline. Participant flow through the study has been
described in earlier publications (e.g. Geschwind et al.,
2011). No harm or unintended treatment effects were
reported in either group.
3.2. Effects of MBCT on self-reported suicidality
The interaction between study periods (baseline vs. post
assessment) and treatment group (control vs. MBCT)
on suicidal ideation was significant (F = 7.226; p = 0.008;
η2 = 0.054). This interaction effect is depicted in Fig. 1. Post-
hoc tests showed a significant reduction of suicidal ideation in
the MBCT-group (t = 2.73; p = 0.008; d = 0.42) but not in
the waiting list control-group (t = 0.83; p = 0.41; d = −0.08).
Neither change in depression (F = 0.409; p = 0.52; η2 =
0.003), nor change in mindfulness (F = 0.089; p = 0.77;
η2 = 0.001), nor in rumination (F = 0.088; p = 0.77; η2 =
0.369; p = 0.54, η2 = 0.003) and treatment group (F = 0.487;
p = 0.49; η2 = 0.004) were not significant.4. Discussion
The present study investigated the effects of MBCT on
suicidal ideation in an open-label randomised controlled trial
with patients suffering from residual depressive symptoms. A
second aim was to examine whether an effect of MBCT on
suicidal ideation was dependent on reductions in depression
severity, worry and rumination, or an increase in mindfulness.
Results revealed that MBCT significantly reduced self-
reported suicidal ideation. Whereas in the wait list control-
group no significant changes occurred when comparing
baseline and post treatment assessments, a significant
reduction in suicidal ideation was apparent in the MBCT-
group. This interaction effect was independent from the impact
of changes in depression, rumination, and mindfulness.
Table 2
Assessment scores of variables used in the analyses, stratified by treatment group.
Pre assessment Post assessment
MBCT Control MBCT Control
M SD M SD t p M SD M SD t p
mindfulness 119.98 16.90 121.21 16.27 0.42 0.67 134.80 14.38 124.62 16.54 −3.73 0.00
worry 59.67 10.92 59.70 10.07 0.01 0.99 50.56 11.50 56.29 10.30 2.98 0.00
rumination 42.16 9.73 40.77 9.72 −0.81 0.42 34.38 9.82 37.92 10.00 2.03 0.04
depression 10.27 3.69 10.21 3.55 −0.08 0.93 7.14 4.81 9.68 4.04 3.27 0.00
Suicidal ideation 0.31 0.59 0.20 0.50 −1.21 0.23 0.11 0.36 0.25 0.61 1.54 0.13
MBCT = Mindfulness-based cognitive therapy; CONTROL = waitlist control condition.
Fig. 1. Interaction effect of study period with treatment group.
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affected its effect size.
Recent research indicates that suicidal thoughts and
behaviour are not merely parts or symptoms of a depressive
disorder but represent a nosological entity in their own right
[9–12,14,15,17]. This suggests that it cannot be assumed
that psychotherapy for depressive disorders will be equally
effective in reducing suicidal thoughts and behaviour [19].
Although MBCT is an acknowledged type of intervention
for acute and remitted depressive disorders, to date only one
study has examined the effect of MBCT on suicidal ideation
itself [36]. This study did not find a significant effect of
MBCT on suicidal ideation although the effect size was in
the hypothesised direction and not negligible (d = 0.48). In
the present study, with the use of a larger sample size, the
effect size in the MBCT group was similar (d = 0.42).
Moreover, both effect sizes are similar to those effect sizes
reported by Tarrier and colleagues [53]. They conducted a
meta-analysis of studies examining the effect on suicidality
of cognitive–behavioural interventions such as cognitive
therapy, problem-solving or dialectic behaviour therapy. In
25 studies they found an overall medium effect size of
Hedge’s g = −0.59 (CI = −0.81 to −0.37).
The results of the present study suggest that in the
study by Barnhofer and colleagues [36] a small sample size
(N = 14 in the treatment group) may have occasioned a type
II error. To the best of our knowledge, the present study is the
first to suggest that MBCT reduces self-reported suicidal
ideation in a large randomised controlled trial with a sample
of patients with residual depressive symptoms. Barnhofer
and colleages [36] concluded that suicidal ideation has to be
addressed in more detail in order to identify significant
changes through MBCT. They suggest the incorporation of a
psycho-educational component on the impact of suicidal
imagery. This might of course be a reasonable enhancement
of MBCT, especially for suicidal patients. Nevertheless, the
results of the present study suggest that MBCT in its current
form does impact upon suicidal ideation.
Changes in suicidal ideation were independent from
changes in depression. This is in line with the meta-analysis
by Cuijpers and co-workers [19] who included three studies
examining the effect of psychotherapy on suicidal ideation.
The authors reported a meta-regression analysis with theeffect size on suicidal ideation as a dependent variable and
the effect size on depression as a predictor and found no
significant association between both.
Importantly, the present results showed that change
in worry over the intervention period diminished the
group × time effect size on suicidal ideation. Thus, the
interaction effect can be partly explained by reductions in
worrying. This result is in agreement with recent studies
reporting that reductions in worry mediate the effect of
MBCT on depression [29,30]. Furthermore, it might be
interpreted as being in line with the assumption of Kerkhof
and van Spijker [54] who claim that repetitive thinking, such
as worry, may be a proximal risk factor for suicidal
behaviour. According to Watkins [55], repetitive thinking
is characterised as uncontrollable, future-orientated, threat-
ening to major personal concerns, and offering neither
solution nor relief. Watkins [55] also reported suicidal
ideation to be related to worry. Kerkhof and van Spijker [54]
argue that, in line with the differential activation hypothe-
sis [56], worrying can trigger chains of dysfunctional
suicidal thoughts. In line with Williams and colleagues
[32], Kerkhof and van Spijker [54] further assume that
therapeutic interventions focusing on, for example, worry
postponement or mindfulness may be helpful in reducing
suicidal ideation. In the light of these assumptions, the
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helps people to distance themselves from worrying cogni-
tions, which in turn may add to a reduction in suicidality.
Van Aalderen and colleagues [29] demonstrated that the
effects of MBCT on depression severity were mediated by
increases in mindfulness and decreases in rumination. Batink
and coworkers [30] replicated the mediating effect of
mindfulness but did not find a mediating effect of rumination.
The present findings suggest that these variables may play a
less important role in the association between MBCT and
suicidal ideation. In prior investigations, rumination was
associated with suicidal ideation. For example, Krajniak,
Miranda and Wheeler [57] found that individuals with a
history of suicide attempt reported higher levels of suicidal
ideation two years later than individualswithout such a history.
Rumination was a significant mediator of this association. In a
decision tree-based longitudinal risk profiling, Batterham and
Christensen [58], examined an Australian population cohort
and found that rumination was one of the strongest predictors
of suicidal ideation and behaviour after four years. Sowhywas
there no significant association between changes in suicidal
ideation and rumination in the present investigation?
Methodological factors pertaining to the present study may
be important. For example, Batterham and Christensen [58]
used a different instrument to assess rumination. No
information about suicide attempt history was available in
the present study, thus precluding examination of the question
regarding whether rumination was associated with changes
induced by MBCT in the subsample with a history of suicide
attempt. It has to be noted that rumination was significantly
reduced by MBCT in the present sample (see Table 2) which
was not associated with changes in suicidal ideation.
Obviously, a different mechanism of action may have
accounted for the observed effects. One potentially important
variable is peer support. Mindfulness training was group-
based, whereas the waiting list control condition was not.
Social isolation is one of the strongest risk factors for suicidal
ideation; in contrast, marriage, children, and a greater
number of friends are associated with decreased suicide
risk [59]. Additionally, according to contemporary theories
on the development of suicidal ideation and behaviour –
such as the interpersonal theory of suicide [60], or the
integrated motivational–volitional model of suicidal behav-
iour [61] – the absence of reciprocal care is one key
component of a sense of thwarted belongingness that may act
as a motivational moderator or even as a direct predictor of
increases in suicidal ideation. Thus, MBCT delivered in
groups may have reduced suicidal ideation by increasing the
feeling of social belongingness of the participants. This
could mean that any group-based intervention may have
resulted in similar effects. However, Tarrier et al. [53] found
even larger effects for individual than for group-based
cognitive–behavioural treatments. Thus, the medium sized
effect of MBCT on suicidality is most likely not reducible to
a simple effect of the group-setting that would have been also
found in any other therapeutic group.4.1. Strengths and limitations
Some limitations and strengths of the current RCT should
be mentioned. One limitation concerns the absence of an
active control group. Moreover, we had no measure of
MBCT fidelity with respect to both adherence and
competence. The study design does not allow for definite
causal inferences. Suicidal ideation was measured with a
single item. Despite this being common practice in this area
of research [1,2,59] the use of psychometric scales for
suicidal ideation would be desirable and may improve the
reliability of assessments in future investigations. Strengths
include the large sample size and sufficient power for the
analysis of group by time interaction effects. Since MBCT
was originally developed to prevent depressive relapse, the
long-term stability of the results of the present study is of
special interest. Therefore, future research may investigate
the impact of MBCT on self-reported suicidal ideation across
a longer time period.
4.2. Conclusion
In conclusion, the present open-label randomised con-
trolled trial suggests that MBCT may reduce suicidal
ideation in patients with residual depressive symptoms.
The impact of MBCT on suicidal ideation may be partly
mediated by reduction in worry. Our results enlarge the body
of knowledge on the effectiveness of MBCT. Future research
may investigate the long-term stability of MBCT-related
reductions in suicidal ideation and determine whether MBCT
also affects acute suicidal ideation in a similar fashion.Acknowledgment
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